- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
New Start Versus Continuing Users on Aripiprazole: Implications for PolicyNew starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.
Latest:
Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United StatesFor patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.
Latest:
An Intervention for VA Patients With Congestive Heart FailureAn intervention of variable intensity for congestive heart failure showed some improvements but no survival effect, suggesting a tradeoff between intervention cost and intensity and survival benefit.
Latest:
Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With GenericsHigher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.
Latest:
Home Care Program for Patients at High Risk of HospitalizationRandomized controlled trial of a home care program for managed care patients resulted in lower probability of hospital admission and greater patient satisfaction with care.
Latest:
How Do Providers Prioritize Prevention? A Qualitative StudyPrimary care providers utilize many strategies for prioritizing preventive care during time-constrained clinical encounters, in addition to being prompted by clinical reminders.
Latest:
Community as Part of the Prescription: Social Media in Diabetes CareThis commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.
Latest:
Association of Co-pay Elimination With Medication Adherence and Total CostThis study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.
Latest:
Effectiveness of Care Coordination and Health Counseling in Advancing IllnessThis prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.
Latest:
Screening Electronic Veterans' Health Records for Medication DiscontinuationMany patients stop taking medications for chronic conditions, thereby reducing the effectiveness of healthcare. An attempt to screen electronic VA healthcare records to identify patients as they discontinued a medication was not an efficient approach to this problem.
Latest:
New Start Versus Continuing Users on Aripiprazole: Implications for PolicyNew starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.
Latest:
Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and ValueThe shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Latest:
LDL Cholesterol Response and Statin Adherence Among High-Risk Patients Initiating TreatmentNonadherence is common among high-risk patients initiating statins and is associated with suboptimal low-density lipoprotein cholesterol (LDL-C) reduction. LDL-C should be monitored to identify suboptimal response and medication nonadherence.
